regadenoson has been researched along with Atrioventricular Block in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andrikopoulou, E; Bajaj, NS; Brice, L; Doppalapudi, H; Hage, FG; Iskandrian, AE; Morgan, CJ | 1 |
Abdallah, MS; Bateman, TM; Kureshi, F | 1 |
Ananthasubramaniam, K; Cabrera, R; Dhanalakota, S; Husain, Z; Jacobsen, G; Karthikeyan, AS; Palani, G; Pathmanathan, S | 1 |
1 review(s) available for regadenoson and Atrioventricular Block
Article | Year |
---|---|
Incidence of atrioventricular block with vasodilator stress SPECT: A meta-analysis.
Topics: Adenosine; Aged; Atrioventricular Block; Coronary Artery Disease; Exercise Test; Female; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Purines; Pyrazoles; Reproducibility of Results; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents | 2019 |
2 other study(ies) available for regadenoson and Atrioventricular Block
Article | Year |
---|---|
Regadenoson-induced complete heart block and asystole: A real possibility nuclear laboratories should be aware of.
Topics: Aged; Atrioventricular Block; Heart Arrest; Humans; Male; Purines; Pyrazoles; Tomography, Emission-Computed, Single-Photon | 2017 |
Hemodynamic response, arrhythmic risk, and overall safety of regadenoson as a pharmacologic stress agent for myocardial perfusion imaging in chronic obstructive pulmonary disease and bronchial asthma patients.
Topics: Adenosine A2 Receptor Antagonists; Aged; Asthma; Atrioventricular Block; Bronchoconstriction; Chi-Square Distribution; Female; Heart Diseases; Hemodynamics; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Organophosphorus Compounds; Organotechnetium Compounds; Predictive Value of Tests; Pulmonary Disease, Chronic Obstructive; Purines; Pyrazoles; Radiopharmaceuticals; Retrospective Studies; Risk Assessment; Risk Factors; Tachycardia, Supraventricular; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents | 2012 |